[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature
Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
The multidimensional challenge of treating coronavirus disease 2019 (COVID-19): remdesivir is a foot in the door
RT Gandhi - Clinical Infectious Diseases, 2021 - academic.oup.com
There are multiple dimensions to consider when treating COVID-19: the severity of infection,
the goals of treatment, and the intervention being deployed. Most people with symptomatic …
the goals of treatment, and the intervention being deployed. Most people with symptomatic …
[HTML][HTML] Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated international task force …
C Bai, SH Chotirmall, J Rello, GA Alba… - European …, 2020 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …
[HTML][HTML] Current treatment in COVID-19 disease: a rapid review
M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
[HTML][HTML] Safety profile of COVID-19 drugs in a real clinical setting
MN Chiu, M Bhardwaj, SP Sah - European journal of clinical pharmacology, 2022 - Springer
Purpose The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus has affected millions all over the world and has …
syndrome coronavirus 2 (SARS-CoV-2) virus has affected millions all over the world and has …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
[HTML][HTML] Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-Infective Therapy …
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become …
causative agent of coronavirus disease 2019 (COVID-19), which has rapidly become …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Review of registered clinical trials for the treatment of COVID‐19
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …